ProMIS Neurosciences, Inc.
PMN
$0.52
$0.0193.79%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -238.20K | 9.28M | -2.62M | -3.64M | -3.58M |
| Total Depreciation and Amortization | -- | -- | -- | -- | 18.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.91M | -13.35M | -41.10K | 77.70K | -177.50K |
| Change in Net Operating Assets | -3.56M | -2.59M | 1.16M | -6.73M | -18.30K |
| Cash from Operations | -8.72M | -6.67M | -1.50M | -10.29M | -3.76M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -700.00 | -- | -- | -- | -1.30K |
| Cash from Investing | -700.00 | -- | -- | -- | -1.30K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 470.00K | 27.22M | 0.00 | 190.30K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -510.60K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 470.00K | 27.22M | 0.00 | 190.30K | -510.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.25M | 20.54M | -1.50M | -10.10M | -4.27M |